Yahoo
NasdaqGM - Delayed Quote USD

Trupanion, Inc. (TRUP)

27.80 -0.99 (-3.44%)
At close: September 4 at 4:00:00 PM EDT
27.80 0.00 (0.00%)
After hours: September 4 at 7:30:04 PM EDT
Trade TRUP on Coinbase
Chart Range Bar
Loading chart for TRUP
  • Previous Close 28.79
  • Open 28.38
  • Bid 17.75 x 200
  • Ask 30.86 x 200
  • Day's Range 27.57 - 28.57
  • 52 Week Range 21.16 - 46.98
  • Volume 280,655
  • Avg. Volume 449,044
  • Market Cap (intraday) 1.213B
  • Beta (5Y Monthly) 1.45
  • PE Ratio (TTM) 52.45
  • EPS (TTM) 0.53
  • Earnings Date (est.) Nov 5, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 34.25

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, and Continental Europe. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. and changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.

www.trupanion.com

1,121

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

TRUP
25.61%
S&P 500 (^GSPC)
12.75%

1-Year Return

TRUP
37.74%
S&P 500 (^GSPC)
18.71%

3-Year Return

TRUP
5.51%
S&P 500 (^GSPC)
70.93%

5-Year Return

TRUP
69.43%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 392.93M
Earnings 6.83M
Profit Margin 1.74%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
100M
200M
300M
1.3%
1.4%
1.5%
1.6%
1.7%

Analyst Insights

View More

Analyst Price Targets

29.00
34.25 Average
27.80 Current
42.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/26/2026
Analyst Piper Sandler
Rating Action Downgrade
Rating Neutral
Price Action Lowers
Price Target 45 -> 32

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.53%

  • Return on Assets (ttm)

    1.78%

  • Return on Equity (ttm)

    6.07%

  • Revenue (ttm)

    1.52B

  • Net Income Avi to Common (ttm)

    23.21M

  • Diluted EPS (ttm)

    0.53

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    398.49M

  • Total Debt/Equity (mrq)

    26.10%

  • Levered Free Cash Flow (ttm)

    11.55M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: